Agenda & Learning Objectives

Participants in this program will:

  • Explore new therapies in IBD and consider the role of TL1A
  • Explore the role obesity and altered metabolism play in IBD
  • Integrate basic science and clinical practice by participating in a choice of workshops:
    • By the end of this workshop, participants will be able to describe the current status and therapeutic applications of cell-based therapy in IBD
    • By the end of this workshop, participants will be able to discuss the present and emerging roles of artificial intelligence in IBD management.
    • By the end of this workshop, participants will be able to apply strategies for sequencing biologics and small molecules in pediatric IBD patients.
    • By the end of this workshop, participants will be able to evaluate current evidence and best practices for managing IBD during pregnancy.
    Examine the future of monitoring and predicting IBD

NOTE: Junior Investigator Award – Please go to the Call for Abstracts page on the registration site

Time Title/Topic Speakers
08:30

0.1 Welcome 
Nurse and Physician of the Year, CCC-Pfizer Women in IBD Award, CCC-Pfizer Advancing DEI in IBD Award

 CEO, Crohn's and Colitis Canada
08:50 0.2 Opening Remarks – Welcome, program objectives 
CO-CHAIRS:
Remo Panaccione & Hillary Steinhart
09:00 0.3 Crohn's and Colitis Overview (15 mins)

Kate Lee

Session I: On the Horizon: New therapies in IBD 
SESSION CHAIR:
Jeffrey McCurdy
09:15

1.1 Plenary Presentation
Molecular Target Discovery in IBD

 Dermot McGovern
09:35

1.2 Plenary Presentation
New Therapies with a Focus on TL1As

 Vipul Jairath
09:55

1.3 Ask-the Expert Panel Session

 MODERATOR: Jeffrey McCurdy
PANEL: Vipul Jairath, Dermot McGovern, Remo Panaccione
10:15

1.4 Junior Investigator Award & Presentation

 TBA
10:35 Refreshment Break (15 minutes)  

Session II: What does fat have to do with it?

 SESSION CHAIR: Jean-Eric Ghia
10:50

2.1 Plenary Presentation
Established and emerging indications for GLP-1 medicines

 Daniel Drucker
11:10

2.2 Plenary Presentation
Obesity and Fat Metabolism in IBD

 Joelle St. Pierre
11:30 2.3 Ask-the Expert Panel Session MODERATOR: Jean-Eric Ghia
PANEL: Daniel Drucker, Maitreyi Raman, Joelle St. Pierre
11:50 2.4 Rising Star Award & Presentation  
12:10 Lunch Break (50 minutes)  

Session III: Workshops – Hot Topics from Bench to Policy
13:00 Placement into Workshops  
13:05

3.1 Workshop
Cell Based Therapies in IBD: Past, present and future

 Theodore Steiner & Ryan Ungaro

3.2 Workshop
Optimizing AI in the Management of IBD

 Michael Byrne & Peter Rossos

3.3 Workshop
Advances Sequencing of Biologics and Small Molecules in Pediatrics

 Anne Griffiths & Sally Lawrence

3.4 Workshop
Sex, Drugs and Rock and Role: Pregnancy and IBD

 Vivian Huang & Cynthia Seow
13:50 Grab and Go Break (10 minutes)  

Session IV: The Future of Monitoring in IBD

 SESSION CHAIR: Eric Benchimol
14:00 4.0 Women in IBD Research Award and DEI in IBD Award Winners  
14:25

4.1 Plenary Presentation
Predicting who will develop IBD: State of the Art 2025

 Sun-Ho Lee
14:45

4.2 Plenary Presentation
Prevention of IBD: Where we are and where we need to go 

 Ryan Ungaro
15:05 4.3 Ask-the Expert Panel Session MODERATOR: Eric Benchimol
PANEL: Sun-Ho Lee, Ryan Ungaro,

Dermot McGovern
15:25 Closing Remarks and Program Evaluation CO-CHAIRS: 
Remo Panaccione & Hillary Steinhart

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.